1. Lewis RA, Norton EW, Gass JD. Acquired arterial macroaneurysms of the retina. Br J Ophthalmol. 1976. 60:21–30.
2. Sekuri C, Kayikcioglu M, Kayikcioglu O. Retinal artery macroaneurysm as initial presentation of hypertension. Int J Cardiol. 2004. 93:87–88.
3. Rabb MF, Gagliano DA, Teske MP. Retinal arterial macroaneurysms. Surv Ophthalmol. 1988. 33:73–96.
4. Russell SR, Folk JC. Branch retinal artery occlusion after dye yellow photocoagulation of an arterial macroaneurysm. Am J Ophthalmol. 1987. 104:186–187.
5. Zhao P, Hayashi H, Oshima K, et al. Vitrectomy for macular hemorrhage associated with retinal arterial macroaneurysm. Ophthalmology. 2000. 107:613–617.
6. Kim DH, Yu HG. Clinical results of vitrectomy in macular hemorrhage from a ruptured retinal artery macroaneurysm. J Korean Ophthalmol Soc. 2010. 51:961–966.
7. Wenkstern AR, Petersen H. Intravitreal ranibizumab in retinal macroaneurysm. Graefes Arch Clin Exp Ophthalmol. 2010. 248:1667–1670.
8. Chanana B, Azad RV. Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye (Lond). 2009. 23:493–494.
9. Jonas JB, Schmidbauer M. Intravitreal bevacizumab for retinal macroaneurysm. Acta Ophthalmol. 2010. 88:e284.
10. Javey G, Moshfeghi AN, Moshfeghi AA. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010. 41:e1–e5.
11. Brown DM, Sobol WM, Folk JC, Weingeist TA. Retinal arteriolar macroaneurysms: long-term visual outcome. Br J Ophthalmol. 1994. 78:534–538.
12. Ohno-Matsui K, Hayano M, Futagami S, et al. Spontaneous involution of a large retinal arterial macroaneurysm. Acta Ophthalmol Scand. 2000. 78:114–117.
13. Tashimo A, Mitamura Y, Ohtsuka K, et al. Macular hole formation following ruptured retinal arterial macroaneurysm. Am J Ophthalmol. 2003. 135:487–492.
14. Ciardella AP, Barile G, Schiff W, et al. Ruptured retinal arterial macroaneurysm associated with a stage IV macular hole. Am J Ophthalmol. 2003. 135:907–909.
15. Kim JY, Lee EK. Full thickness macular hole formation following rupture of reinal arterial macoraneur. J Korean Ophthalmol Soc. 2007. 48:1429–1432.
16. Tsujikawa A, Sakamoto A, Ota M, et al. Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography. Retina. 2009. 29:782–792.
17. Kim YH, Kim ES, Yu SY, Kwak HW. Long-term effect of intravitreal bevacizumab for CNV secondary to age-related macular degeneration. J Korean Ophthalmol Soc. 2008. 49:1935–1940.
18. Kim JY, Kweon EY, Lee DW, Cho NC. Results of intravitreal bevacizumab for macular edema with retinal vein occlusion and diabetic macular edema. J Korean Ophthalmol Soc. 2008. 49:1275–1282.
19. Tonotsuka T, Imai M, Saito K, Iijima H. Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol. 2003. 47:498–502.
20. Saito K, Iijima H. Visual prognosis and macular pathology in eyes with retinal macroaneurysms. Nihon Ganka Gakkai Zasshi. 1997. 101:148–151.
21. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol. 1995. 113:62–69.
22. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999. 106:1900–1906.
23. Johnson MW. Pneumatic displacement of submacular hemorrhage. Curr Opin Ophthalmol. 2000. 11:201–206.
24. Mainster MA, Whitacre MM. Dye yellow photocoagulation of retinal arterial macroaneurysms. Am J Ophthalmol. 1988. 105:97–98.